Skip to main content

$0.220 (0%)

High

-

Low

-

Trades

-

Turnover

$0

Volume

0
10 June 2026 at 7:18am
Register to track AYA and receive email alerts.
Subject
AYA Ann: Notification regarding unquoted securities - AYA

AYA Ann: Notification regarding unquoted securities - AYA

AYA Ann: Notification regarding unquoted securities - AYA

AYA Ann: Change of Director's Interest Notice - Bernie Ridgeway

AYA Ann: Change of Director's Interest Notice - John Barrington

AYA Ann: Change of Director's Interest Notice - Bernie Ridgeway

AYA Ann: Artrya Appoints Accomplished American Physician as CMO

AYA Ann: Conference Call - Update on US FDA Application

AYA Ann: Update on US FDA Application for Artrya Salix

AYA Ann: Change of Director's Interest Notice - John Barrington

AYA Ann: Artrya Signs First U.S. Hospital Clinical Partnership

AYA Ann: Application for quotation of securities - AYA

AYA Ann: Quarterly Activity Report and Appendix 4C for Q3 FY22

AYA Ann: Change of Registered Office

AYA Ann: Application for quotation of securities - AYA

AYA Ann: Quarterly Conference Call Details

AYA Ann: Release of Shares from Escrow

AYA Ann: Change of Director's Interest Notice - Bernie Ridgeway

AYA Ann: Notification regarding unquoted securities - AYA

AYA Ann: Change of Director's Interest Notice - Bernie Ridgeway

AYA Ann: Artrya Opens US Operations in Los Angeles

AYA Ann: Change of Director's Interest Notice - Bernie Ridgeway

AYA Ann: Change of Director's Interest Notice - Bernie Ridgeway

AYA Ann: Change of Director's Interest Notice - Bernie Ridgeway

AYA Ann: Artrya Half Year Financial Report Presentation

AYA Ann: Appendix 4D and Half Year Financial Report

AYA Ann: Change of Director's Interest Notice - Bernie Ridgeway

AYA Ann: Half Year Financial Report & Shareholder Conference Call

AYA Ann: Change of Director's Interest Notice - Bernie Ridgeway

AYA Ann: Quarterly Results Conference Call

AYA Ann: Quarterly Activity Report and Appendix 4C for Q2 FY22

AYA Ann: Notification regarding unquoted securities - AYA

AYA Ann: Artrya appoints Dr Jacque Sokolov as United States Advisor

AYA Ann: Artrya Update December 2021

AYA Ann: Notice of Initital Substantial Holder - Artrya Limited

AYA Ann: Notice of Initial Substantial Holder - John Konstantopoulos

AYA Ann: Notice of Initial Substantial Holder - John Barrington

AYA Ann: Initial Director's Interest Notice - Bernie Ridgeway

AYA Ann: Initial Director's Interest Notice - John Konstantopoulos

AYA Ann: Initial Director's Interest Notice - John Barrington AM

AYA Ann: Cardiac imaging software company Artrya Lists on ASX

AYA Ann: Pre-Quotation Disclosure

AYA Ann: Top 20 Holders

AYA Ann: Distribution Schedule

AYA Ann: Securities Trading Policy

AYA Ann: Corporate Governance Statement

AYA Ann: Incentive Awards Plan 2021

AYA Ann: Employee Option Plan 2019

AYA Ann: Financial Report for period ended 30 June 2021

AYA Ann: Financial Report for period ended 30 June 2020

Register to track AYA and receive email alerts.